Liu D - Search Results

1

New clinical developments in histone deacetylase inhibitors for epigenetic therapy of cancer.

Cang S, Ma Y, Liu D. Cang S, et al. Among authors: liu d. J Hematol Oncol. 2009 Jun 1;2:22. doi: 10.1186/1756-8722-2-22. J Hematol Oncol. 2009. PMID: 19486511 Free PMC article. Review.

2

Phenylhexyl isothiocyanate inhibits histone deacetylases and remodels chromatins to induce growth arrest in human leukemia cells.

Ma X, Fang Y, Beklemisheva A, Dai W, Feng J, Ahmed T, Liu D, Chiao JW. Ma X, et al. Among authors: liu d. Int J Oncol. 2006 May;28(5):1287-93. Int J Oncol. 2006. PMID: 16596246

3

Phenylhexyl isothiocyanate has dual function as histone deacetylase inhibitor and hypomethylating agent and can inhibit myeloma cell growth by targeting critical pathways.

Lu Q, Lin X, Feng J, Zhao X, Gallagher R, Lee MY, Chiao JW, Liu D. Lu Q, et al. Among authors: liu d. J Hematol Oncol. 2008 Jun 9;1:6. doi: 10.1186/1756-8722-1-6. J Hematol Oncol. 2008. PMID: 18577263 Free PMC article.

4

P-loop mutations and novel therapeutic approaches for imatinib failures in chronic myeloid leukemia.

Cang S, Liu D. Cang S, et al. Among authors: liu d. J Hematol Oncol. 2008 Oct 1;1:15. doi: 10.1186/1756-8722-1-15. J Hematol Oncol. 2008. PMID: 18828913 Free PMC article. Review.

5

t(3;9;22) 3-way chromosome translocation in chronic myeloid leukemia is associated with poor prognosis.

Tan J, Cang S, Seiter K, Primanneni S, Ahmed N, Mathews T, Liu D. Tan J, et al. Among authors: liu d. Cancer Invest. 2009 Aug;27(7):718-22. doi: 10.1080/07357900802653498. Cancer Invest. 2009. PMID: 19308813 Review.

6

Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents.

Tan J, Cang S, Ma Y, Petrillo RL, Liu D. Tan J, et al. Among authors: liu d. J Hematol Oncol. 2010 Feb 4;3:5. doi: 10.1186/1756-8722-3-5. J Hematol Oncol. 2010. PMID: 20132536 Free PMC article. Review.

7

Novel agents and regimens for acute myeloid leukemia: 2009 ASH annual meeting highlights.

Zhu X, Ma Y, Liu D. Zhu X, et al. Among authors: liu d. J Hematol Oncol. 2010 Apr 23;3:17. doi: 10.1186/1756-8722-3-17. J Hematol Oncol. 2010. PMID: 20416083 Free PMC article. Review.

8

Current management and novel agents for malignant melanoma.

Lee B, Mukhi N, Liu D. Lee B, et al. Among authors: liu d. J Hematol Oncol. 2012 Feb 14;5:3. doi: 10.1186/1756-8722-5-3. J Hematol Oncol. 2012. PMID: 22333219 Free PMC article. Review.

9

Recent advances and novel agents for gastrointestinal stromal tumor (GIST).

Lamba G, Ambrale S, Lee B, Gupta R, Rafiyath SM, Liu D. Lamba G, et al. Among authors: liu d. J Hematol Oncol. 2012 May 8;5:21. doi: 10.1186/1756-8722-5-21. J Hematol Oncol. 2012. PMID: 22569033 Free PMC article. Review.

10

Novel CD20 monoclonal antibodies for lymphoma therapy.

Cang S, Mukhi N, Wang K, Liu D. Cang S, et al. Among authors: liu d. J Hematol Oncol. 2012 Oct 11;5:64. doi: 10.1186/1756-8722-5-64. J Hematol Oncol. 2012. PMID: 23057966 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38,035 results

Search Page

Filters